CoChat

The DOI matches its Crossref record; 106 of the 111 references it cites were found in a registry or an index; 12 of the 36 sources its claims cite were checked for support.

Acceptance and commitment therapy for autistic adults: A randomized controlled pilot study in a psychiatric outpatient setting.

Open access

Abstract

Autistic adults are at risk of stress-related psychiatric disorders and reduced life quality due to social, cognitive, and perceptual challenges. Mental health interventions adapted to autistic adults are scarce. Acceptance and commitment therapy has preliminarily indicated health benefits in autistic adults, although it has not been robustly evaluated. Overall, 39 adults (21 males; 21–72 years) with autism spectrum disorder and normal intellectual ability (IQ M = 108.5; SD = 13.5) were randomized to 14 weeks of adapted acceptance and commitment therapy group treatment (NeuroACT) or treatment as usual. The intervention was feasible. Perceived stress and quality of life (primary outcomes), alongside psychological inflexibility, cognitive fusion, cognitive and behavioral avoidance, and autistic mannerism were statistically significantly improved in NeuroACT compared with treatment as usual (d = 0.70–0.90). Clinically significant changes in perceived stress and quality of life were in favor of NeuroACT. Between-group altered depression, anxiety, sleep problems, one quality of life measure, functional impairment, social aspects of autism, and executive difficulties were statistically non-significant. Dropout was slightly higher in NeuroACT. NeuroACT may be a promising treatment for autistic adults with co-existing stress and reduced quality of life. More extensive studies are warranted to evaluate NeuroACT further. Autistic adults are often stressed and feel depressed or anxious. However, mental health programs that are suited for autistic adults are few. Acceptance and commitment therapy is a psychotherapy method that seems to help people feel better, although not thoroughly evaluated in autistic individuals. In this study, 20 autistic adults had 14 weeks of acceptance and commitment therapy group treatment suited for autism (NeuroACT), while 19 autistic adults had ordinary care. The acceptance and commitment therapy group treatment program seemed logical and reasonable to the participants. Also, when comparing the participants in the NeuroACT group with those in the ordinary care group, the NeuroACT participants reported less stress and higher quality of life. Compared to the ordinary care group, they could also manage distressing thoughts better, perceived themselves as more flexible, and did not avoid stressful situations as much as before. However, there was no significant difference between the groups in depression, anxiety, sleep problems, social aspects of autism, everyday functioning, or executive challenges. Slightly more NeuroACT participants did not finish the treatment than ordinary care participants. In conclusion, the NeuroACT program may be a treatment for autistic adults who feel stressed and have reduced quality of life. More studies are needed to see how helpful the NeuroACT program is for autistic adults.

Overview

CoChat Summary

## TL;DR

This randomized controlled pilot trial found that a 14-week autism-adapted ACT group program (NeuroACT) was feasible in a psychiatric outpatient setting and showed better outcomes than treatment as usual for perceived stress and quality of life. It also improved several ACT-related processes, but not depression, anxiety, sleep problems, functional impairment, social aspects of autism, or executive difficulties.

## Key findings

  • Sample and feasibility: 39 autistic adults were randomized (20 NeuroACT, 19 TAU); 75% of 52 screened were invited, 100% of invited participants joined, 85% of NeuroACT participants completed treatment, and 87% completed all assessments at T1, T2, and T3.
  • Primary outcomes: The rmANOVA showed a statistically significant group-by-time interaction favoring NeuroACT on perceived stress (PSS) with a moderate effect size; stress decreased from T1 to T2 but not from T2 to T3. NeuroACT also outperformed TAU on one quality-of-life measure (SWLS) with a moderate effect size, but not on QOLI.
  • Secondary outcomes: NeuroACT showed significant group-by-time effects with moderate to large effect sizes on psychological inflexibility (AAQ), cognitive fusion (CFQ), and cognitive/behavioral avoidance (CBAS), and on autistic mannerism (SRS-AM).
  • Null findings: No statistically significant between-group effects were found for depression (BDI-II), anxiety (BAI), sleep problems (KSQ indices), functional impairment (SDS), overall autistic core challenges/SRS total, social motivation/awareness/cognition/communication, or executive difficulties (DEX).

## Methods

  • Design: Randomized, two-group controlled pilot trial with repeated measures at pre-treatment (T1), post-treatment (T2), and 6-month follow-up (T3); block randomization 1:1 to NeuroACT vs TAU.
  • Sample/data: 39 adults with ASD from a psychiatric outpatient clinic in Stockholm; participants were 21 men and 18 women, aged 21–72 years (mean age 39, SD 12), with mean IQ 108.5 (SD 13.5).
  • Main analysis: Outcome data were analyzed with mixed-design repeated-measures ANOVA (group × time), with Kruskal–Wallis/Wilcoxon tests for non-normal variables and effect sizes reported as Cohen’s d; analyses were performed on treatment completers.
  • Intervention: NeuroACT was a 14-week, manualized group ACT program adapted for autism, delivered in 14 weekly 150-minute sessions with homework and mindfulness/acceptance अभ्यास; TAU participants received ordinary care and were offered NeuroACT with a 1-year delay.

## Limitations

  • The paper explicitly states: small sample size reducing power and increasing risk of type 2 error; risk of type 1 error due to many outcome measures; reliance on self-report without objective/independent criteria; setting-specific limits to generalizability; lack of control for group effects; and restricted generalizability because participants had average or above-average intellectual capacity.
  • Evident from the text: the trial was prematurely aborted before the planned sample size of 60 was reached, so estimates are based on a small pilot sample.
  • Evident from the text: the authors report that outcome analyses were done on treatment completers, which may limit inference if dropout differed between groups.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1177/13623613221140749

Cites

106 of 106 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1. Flowchart of procedure and participants.
Figure 1. Flowchart of procedure and participants.CC BY · PubMed Central

Verification

Claims the paper makes

11 Valid · 0 Not valid · 13 Not checked · 82 Own results and interpretations

59 more claims

Create a free account to see all 106 claims and every source verdict.

See all claims — free account
  • It may state two separate claims as one. 28
  • Probably not a substantial claim. 21
  • The quote only partly states this claim. 1

Create a free account to see these claims.

Citations

Cites

Show all 111 references

Research works printed but not linked: 4

  1. Conners C. K., 2000, Conners’ continuous performance test II: Technical guide
  2. Frisch M. B., 1994, Quality of Life Inventory: Manual and treatment guide
  3. LeClerc S., 2015, Pharmacy and Therapeutics, 40, 389
  4. Wechsler D., 1997, WAIS-III: Wechsler Adult Intelligence Scale

Cited by

See all 20

Metadata

Authors
Pahnke, J., Jansson-Fröjmark, M., Andersson, G., Bjureberg, J., Jokinen, J., Bohman, B., & Lundgren, T.
Affiliations
  • Region Stockholm (SE)
  • Karolinska Institutet and Region Stockholm, Sweden
  • Linköping University (SE)
  • Umeå University (SE)
Corresponding author
Pahnke, Johan
Venue
Autism
Published
2022-12-13
Volume
27
Issue
5
Pages
1461-1476
ISSN
  • 1362-3613 (ISSN-L)
  • 1461-7005
OpenAlex
W4311284441
Cited by
19
References
111
Citations by year
2026: 12 · 2025: 1 · 2024: 6 · 2023: 1
FWCI
0.85
Type
journal article
Language
en
Open access
Locations
  • Autism (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • KTH Publication Database DiVA (KTH Royal Institute of Technology) (submittedVersion, other-oa)
  • PubMed Central (submittedVersion, cc-by)
Funders
  • L. J. Boëthius Foundation
  • Söderström-Königska Foundation
  • Psykiatrifonden
  • Stiftelsen Professor Bror Gadelius Minnesfond
Topics
  • Life Sciences › Neuroscience › Cognitive Neuroscience › Autism Spectrum Disorder Research
  • Social Sciences › Psychology › Clinical Psychology › Family and Disability Support Research
  • Social Sciences › Psychology › Clinical Psychology › Mindfulness and Compassion Interventions
Keywords
acceptance and commitment therapy, autism spectrum disorder, autistic adults, perceived stress, quality of life, psychological inflexibility, cognitive fusion, avoidance
MeSH terms
Autism Spectrum Disorder, Adult, Autistic Disorder, Humans, Outpatients, Pilot Projects, Quality of Life, Acceptance and Commitment Therapy

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Acceptance and commitment therapy for autistic adults: A randomized controlled pilot study in a psychiatric outpatient setting. https://app.cochat.ai/papers/10.1177/13623613221140749
The paper
Pahnke, J., Jansson-Fröjmark, M., Andersson, G., Bjureberg, J., Jokinen, J., Bohman, B., & Lundgren, T. (2023). Acceptance and commitment therapy for autistic adults: A randomized controlled pilot study in a psychiatric outpatient setting. Autism. https://doi.org/10.1177/13623613221140749

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.